Business
Press Release Sep 14 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 14, 2023, titled "Strides receives tentative USFDA approval for Dolutegravir tablets".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 14, 2023, titled \"Strides receives tentative USFDA approval for Dolutegravir tablets\". View Attachment","length":333,"tagName":"div"}]